Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01092689

The Role of Meat-borne Carcinogens in Pancreatic Cancer

Understanding the Role of Meat-Borne Carcinogen in Pancreatic Cancer Etiology

Status
Withdrawn
Phase
Phase 1
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Minnesota · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

We propose to recruit subjects scheduled for pancreatectomy as a treatment for pancreatic cancer. These subjects will ingest a very low dose of radiolabeled PhIP, a meat-derived carcinogen, and a small amount of resected tissue (waste) will be analyzed with highly sensitive technology to determine if this carcinogen binds to DNA in the pancreas.

Detailed description

Pancreatic cancer is rapidly fatal in most cases and little is known about its causes. Identifying and modifying risk factors can reduce mortality through prevention. Carcinogens that form in meat cooked at high temperatures may be modifiable risk factors for pancreatic cancer, but direct evidence is needed to demonstrate involvement in pancreas tissue. We propose to recruit subjects scheduled for pancreatectomy as a treatment for pancreatic cancer. These subjects will ingest a very low dose of radiolabeled PhIP, a meat-derived carcinogen, and a small amount of resected tissue (waste) will be analyzed with highly sensitive technology to determine if this carcinogen binds to DNA in the pancreas. We hypothesize that the meat-derived carcinogen will bind to DNA in the pancreas. The amount of PhIP ingested is equivalent to the amount in two very well-done barbecued chicken breasts and the dose of radioactivity is comparable to a typical chest x-ray. This research can increase understanding of pancreatic carcinogenesis, facilitating the design of prevention strategies.

Conditions

Interventions

TypeNameDescription
DRUGPhiP1 capsule of 84 micrograms; 15.6 micro-curies \[14C\]PhIP

Timeline

Start date
2012-01-01
Primary completion
2012-01-01
Completion
2012-01-01
First posted
2010-03-25
Last updated
2020-06-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01092689. Inclusion in this directory is not an endorsement.